A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
make certain changes with respect to the approval of 
abbreviated applications for the approval of new animal 
drugs, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Generic Animal Drug 
4
Advancement Act’’. 
5
22:27 Sep 21, 2022
H8857
2 
•HR 8857 IH
SEC. 2. CHANGES TO PROCESS FOR APPROVAL OF ABBRE-
1
VIATED APPLICATIONS FOR THE APPROVAL 
2
OF NEW ANIMAL DRUGS. 
3
Section 512 of the Federal Food, Drug, and Cosmetic 
4
Act (21 U.S.C. 360b) is amended— 
5
(1) in subsection (d)(4), in the matter pre-
6
ceding subparagraph (A), by striking ‘‘section 
7
512(b)(1)’’ and inserting ‘‘paragraph (1) or (2) of 
8
subsection (b)’’; 
9
(2) in subsection (n)(1)(F)— 
10
(A) by striking ‘‘or because the new animal 
11
drug’’ and inserting ‘‘because the new animal 
12
drug’’; 
13
(B) by striking ‘‘manufacturers;’’ and in-
14
serting ‘‘manufacturers, or because the new 
15
animal drug is not shown to be bioequivalent to 
16
all of the species for which the approved new 
17
animal drug is approved for use’’; and 
18
(3) by amending subsection (o) to read as fol-
19
lows: 
20
‘‘(o) For purposes of this section— 
21
‘‘(1) the term ‘bioequivalent’ means, in estab-
22
lishing whether a new animal drug is bioequivalent 
23
to an approved new animal drug— 
24
22:27 Sep 21, 2022
H8857
3 
•HR 8857 IH
‘‘(A) demonstrating bioequivalence in at 
1
least one major species for which the approved 
2
new animal drug is approved for use; or 
3
‘‘(B) in the case that an approved new ani-
4
mal drug is not approved for use in any major 
5
species, demonstrating bioequivalence in at least 
6
one species for which the approved new animal 
7
drug is approved for use; and 
8
‘‘(2) the term ‘patent’ means a patent issued by 
9
the United States Patent and Trademark Office;’’. 
10
Æ 
22:27 Sep 21, 2022
H8857
